Company profile for Opterion Health

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Opterion Health, founded in 2012 and based in Switzerland, is dedicated to innovating peritoneal dialysis (PD) to improve quality of life and outcomes for chronic kidney disease patients. As a research-driven, privately held company, Opterion is developing novel PD solutions—the first major innovation in two decades—including a glucose-free option that reduces metabolic challenges and benefits diabetic patients. With two n...
Opterion Health, founded in 2012 and based in Switzerland, is dedicated to innovating peritoneal dialysis (PD) to improve quality of life and outcomes for chronic kidney disease patients. As a research-driven, privately held company, Opterion is developing novel PD solutions—the first major innovation in two decades—including a glucose-free option that reduces metabolic challenges and benefits diabetic patients. With two novel approaches in development, Opterion aims to enhance PD’s medical utility, flexibility, and affordability for patients worldwide.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Switzerland
Address
Address
Hofackerstrasse 40, CH-4132 Muttenz
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/01/3196657/0/en/Opterion-Health-AG-Announces-Appointment-of-Andreas-Schuh-as-Chief-Financial-Officer.html

GLOBENEWSWIRE
01 Dec 2025

https://www.globenewswire.com/news-release/2025/09/17/3151371/0/en/Opterion-Health-AG-submits-Clinical-Trial-Application-for-First-in-Human-Study-of-OPT101-in-Patients-with-Advanced-Chronic-Kidney-Disease.html

GLOBENEWSWIRE
17 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty